Adaptimmune, an Oxford, U.K.-based biopharmaceutical company, has moved its U.S. operations from the University City Science Center and will relocate to a new facility at the Philadelphia Navy Yard, the company said Friday.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Fri, 10/09/2015 - 9:12am
Adaptimmune, an Oxford, U.K.-based biopharmaceutical company, has moved its U.S. operations from the University City Science Center and will relocate to a new facility at the Philadelphia Navy Yard, the company said Friday.